This article addresses the critical challenge of translating promising preclinical findings into clinical success, a persistent bottleneck in drug development.
This article synthesizes the latest methodologies and validation frameworks for improving the sensitivity and specificity of early detection tests, with a focus on cancer and other diseases.
This comprehensive review addresses the critical challenge of immune-related adverse events (irAEs) associated with cancer immunotherapy, particularly immune checkpoint inhibitors.
This article provides a comprehensive analysis of the current limitations in cancer diagnostics, exploring the foundational biological, technological, and systemic barriers that hinder accurate and timely detection.
Immunotherapy has revolutionized cancer treatment, yet patient response rates remain variable, underscoring the critical need for robust predictive biomarkers.
This article provides a comprehensive analysis for researchers and drug development professionals on the critical challenge of tumor heterogeneity in targeted cancer therapy.
Cancer stem cells (CSCs) are a therapy-resistant subpopulation that drive tumor initiation, progression, metastasis, and relapse.
This article provides a comprehensive overview of the current landscape of Chimeric Antigen Receptor (CAR)-T cell engineering and manufacturing.
This article provides a comprehensive overview of liquid biopsy technologies for cancer monitoring, tailored for researchers, scientists, and drug development professionals.
Spatial transcriptomics (ST) has emerged as a transformative technology that preserves the spatial context of gene expression within intact tissues, providing unprecedented insights into the complex architecture of the tumor...